Arecor
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Cambridge Science Park, Cambridge, Cam...Phone Number
+44 1223426060Website
www.arecor.comRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Arecor
Arecor is a clinical stage biopharmaceutical company specializing in drug development and delivery for diabetes and other cardiometabolic diseases. Utilizing their proprietary Arestat technology platform, they are focused on creating enhanced therapeutic medicines for diabetes and obesity. The company collaborates with leading pharmaceutical and medtech firms to advance their innovative treatments. Arecor is supported by a robust intellectual property portfolio, ensuring the validation of their technology.Explore more
Arecor Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arecor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Arecor had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Arecor has new funding data
Check if Arecor has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Arecor recently announced quarterly report
Check out if Arecor is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Arecor
Arecor, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Arecor launches new products
Recommended Actions
Find VP level buyers at Arecor
Find 3 more new buyers
Compare Similar Companies to Arecor
Compare insights from companies similar to Arecor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Arecor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Arecor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Arecor.
Arecor financials insights
Gather financial insights about Arecor, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$230K
2018
Unspecified
$7.8M
Arecor Tech Stack
A closer look at the technologies used by Arecor
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Executive Move
Executive Moves, Seeking Replacement
Left Company
Executive Move
Executive Moves, Left Company
Mergers & Acquisitions (M&A)
Arecor News & Media
Rainbow Rare Earths, Cloudbreak Discovery, Valereum, Arecor Therapeutics, Wellnex Life
Rainbow Rare Earths Ltd (AIM:RBW, ASX:RRE) says its Johannesburg pilot plant is performing to plan and has produced commercial-grade rare earth product. The company says the quality de-risks the project and supports plans to move further downstream. Cloudbreak Discovery PLC (LSE:CDS) shares jumped after it moved to buy 90% of the Paterson gold-copper project in Western Australia. The company plans modern geophysics to refine drill targets near Greatland Gold’s Telfer mine. Valereum PLC (LSE:VLRMArecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292
Arecor Therapeutics announces Co-development Agreement for AT278 with Sequel Med Tech and Sale of Royalty and Technology Access Fees for up to $11mSkye Bioscience Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab
Proprietary formulation technology being applied to potentially enhance properties of nimacimab Proprietary formulation technology being applied to potentially enhance properties of nimacimabArecor Appoints Interim Chief Financial Officer | Company Announcement - Investegate
Investegate announcements from Arecor Appoints Interim Chief Financial Officer
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Arecor
Sign Up For FreeTo access detailed company insights
Arecor is a clinical stage biopharmaceutical company specializing in drug development and delivery for diabetes and other cardiometabolic diseases. Utilizing their proprietary Arestat technology platform, they are focused on creating enhanced therapeutic medicines for diabetes and obesity. The company collaborates with leading pharmaceutical and me... Read More
